BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15297563)

  • 1. Two novel clinical presentations of Burkholderia cepacia infection.
    Mukhopadhyay C; Bhargava A; Ayyagari A
    J Clin Microbiol; 2004 Aug; 42(8):3904-5. PubMed ID: 15297563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
    J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent bacteraemia caused by a single clone of Burkholderia cepacia with unusual phenotype.
    Teng LJ; Hsueh PR; Pan HJ; Ho SW; Luh KT
    J Infect; 2001 Apr; 42(3):202-5. PubMed ID: 11545553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
    Henry DA; Mahenthiralingam E; Vandamme P; Coenye T; Speert DP
    J Clin Microbiol; 2001 Mar; 39(3):1073-8. PubMed ID: 11230429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
    Herasimenka Y; Cescutti P; Impallomeni G; Campana S; Taccetti G; Ravenni N; Zanetti F; Rizzo R
    J Cyst Fibros; 2007 Apr; 6(2):145-52. PubMed ID: 16860003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Burkholderia cepacia: a new pathogen causing nosocomial infections].
    Lipowski D; Rzadkiewicz E; Czekalska-Lachowicz E
    Przegl Epidemiol; 2008; 62(1):7-17. PubMed ID: 18536220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia cepacia endophthalmitis: clinico-microbiologic profile and outcomes.
    Sachdeva V; Pathengay A; Joseph J; Sharma S; Das T
    Retina; 2011 Oct; 31(9):1801-5. PubMed ID: 21478807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
    Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
    Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR-RFLP analysis of the flagellin sequences for identification of Burkholderia pseudomallei and Burkholderia cepacia from clinical isolates.
    Tungpradabkul S; Wajanarogana S; Tunpiboonsak S; Panyim S
    Mol Cell Probes; 1999 Apr; 13(2):99-105. PubMed ID: 10208800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical necrotizing fasciitis: a novel clinical presentation of Burkholderia cepacia infection.
    Marioni G; Rinaldi R; Ottaviano G; Marchese-Ragona R; Savastano M; Staffieri A
    J Infect; 2006 Nov; 53(5):e219-22. PubMed ID: 16545459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy for the isolation and identification of environmental Burkholderia cepacia complex bacteria.
    Vanlaere E; Coenye T; Samyn E; Van den Plas C; Govan J; De Baets F; De Boeck K; Knoop C; Vandamme P
    FEMS Microbiol Lett; 2005 Aug; 249(2):303-7. PubMed ID: 16000240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
    Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
    APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of Burkholderia cepacia endophthalmitis.
    Eser I; Altan T; Stahl JE; Aydin MD; Inan N; Kapran Z; Yilmaz OF
    Br J Ophthalmol; 2006 Sep; 90(9):1211. PubMed ID: 16929075
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic Burkholderia multivorans bronchial infection in a non-cystic fibrosis individual with mannose binding lectin deficiency.
    Whitehouse JL; Exley AR; Foweraker J; Bilton D
    Thorax; 2005 Feb; 60(2):168-70. PubMed ID: 15681508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
    Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
    Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkholderia cepacia infection and lung transplantation.
    Husain S; Singh N
    Semin Respir Infect; 2002 Dec; 17(4):284-90. PubMed ID: 12497545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
    Seo ST; Tsuchiya K
    Lett Appl Microbiol; 2004; 39(5):413-9. PubMed ID: 15482431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults.
    Courtney JM; Dunbar KE; McDowell A; Moore JE; Warke TJ; Stevenson M; Elborn JS
    J Cyst Fibros; 2004 Jun; 3(2):93-8. PubMed ID: 15463892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.